The Asus ROG Ally 2 May Have an Xbox Button and Wonky Grips
The Asus ROG Ally 2 may include a dedicated Xbox button, plus some contoured grips.
The Xbox handheld is reportedly real, and it already looks really strange compared to PC handhelds we're used to. Leaked images found on government certification sites offer a glimpse into what is likely Asus' upcoming ROG Ally 2. It's a successor to the ROG Ally released in 2023 and expected to have a more powerful processor and a dedicated Xbox button. While the Asus-Microsoft handheld is turning away from the Steam Deck's brick-like design, the idea of contoured grips may be the thing that takes this device over the top.
91Mobiles found entries at Indonesia's certification office referencing two new models for the Asus ROG Ally 2, and VideoCardz dug up Wi-Fi module listings from the U.S. Federal Communications Commission that you can now see for yourself. Judging by the timing for these filings, we could see the new ROG Ally 2 PC handheld and the Xbox version as soon as this month, perhaps during the Computex computing conference in Taipei, Taiwan set for May 19.
ROG Ally 2
RC73XA Black 20V 5A 100W
RC73YA White 20V 3.25A 65Whttps://t.co/jgx4HFHUUu https://t.co/QUwZwa8t9a pic.twitter.com/dq3CP2SbA9
— Huang514613 (@94G8LA) May 7, 2025
Included in the leaked specifications and images are two models of the supposed sequel to the ROG Ally (though we expect the real deal won't be absolutely filthy with fingerprint smudges). Both the black and white versions house a separate button to the left of what's normally the switch to access Asus' Armoury Crate software. The black version includes an outline for what appears to be the Xbox logo, which indicates this could be the device's rumored Xbox button. The switch may allow quick access to the Xbox app or some other function for the model running Windows. We won't know until we eventually see it in person.
Specs-wise, the ROG Ally 2 could be on the higher end of modern handhelds with a 7-inch, 120Hz LCD display and an AMD Ryzen Z2 Extreme chip that was announced alongside the Lenovo Legion Go 2 back during CES 2025. The black Xbox version may be even more powerful. That APU (accelerated processing unit) is an 8-core processor with a max 36W TDP (thermal design power), allowing it to draw more power from the battery for better in-game performance. The less powerful Ally 2's processor sits at a mere four cores with a 20W TDP. It's very close to the processor that's in the Steam Deck. It may be closer in performance to the AMD Ryzen Z2 Go based on the chipmaker's Zen 3 architecture found in the Legion Go S. The top-end Ally 2 may have up to 64GB of RAM. The versions spotted on the Indonesia listings reportedly came with up to 2TB of storage.
The most striking aspect of the new design is the two molded grips on either end of the device. While it looks odd compared to the traditional brick-like Steam Deck or older ROG Ally design, it actually reminds me more of the Xbox controller—in a good way. We all gave a little chuckle back when Sony released its PlayStation Portal since it was essentially a PlayStation DualSense controller split in half with a display in the middle. But, hell, I enjoy the feel of both the DualSense and Xbox controllers that contour around the palm. The only hangup I can see is whether your palms may dig into the sharp corners where the grips meet the device's main body.
There's a reason these designs for controllers stick around. The most comfortable handheld I've used is the 8-inch Legion Go S with its larger grips, but that device suffered from lower performance considering its $730 price tag. Both ROG Ally 2 models should have two USB-C ports on the top of the device (none on the bottom, apparently). The new handhelds should also have two back buttons, just like the original ROG Ally.
The $800 Asus ROG Ally X stood out from the pack because of its larger amount of RAM combined with an 80Wh battery that helped it last longer than other PC handhelds. We have yet to do our own tests of the Z2 Extreme APU beyond handling trying out the Legion Go 2 earlier this year. It seemed powerful enough, but time will tell how much. As it stands, the Intel Lunar Lake-powered MSI Claw 8 AI+ beats the Ally's Z1 Extreme chip in raw performance, but it now costs $1,000 and you'd be lucky to get one in the states. Judging by rising prices everywhere, we don't expect the ROG Ally 2 will be a cheap device by any standard.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
YXT.com Announces Changes in Board of Directors and Management
SUZHOU, China, June 30, 2025 (GLOBE NEWSWIRE) -- Group Holding Limited (NASDAQ: YXT) (' or the 'Company'), a provider of AI-enabled enterprise productivity solutions, today announced that Mr. Pun Leung Liu has notified the board of directors of the Company (the 'Board') of his decision to resign from his position as a Director and Chief Financial Officer ('CFO') of the Company, effective June 30, 2025, due to personal reasons. Mr. Liu's resignation did not result from any disagreement or dispute with the Company, the Board, or the Company's management regarding any matter relating to the Company's operations, policies, or practices. Following Mr. Liu's resignation, the Board has appointed Mr. Yazhou Wu, the Company's Chief Operating Officer and Chief Technology Officer, as the new Director. The Board has also appointed Mr. Shen Cao, the current Vice President of Investment Relations, as the new CFO. Mr. Shen Cao joined the Company in May 2025 as Vice President of Investment Relations. Prior to joining Mr. Cao served as the Deputy Chairman of the Board in Topsperity Securities Asset Management Co., Ltd. from June 2023 to April 2025. Mr. Cao holds a Bachelor's and Master's degree in Civil Engineering from Tsinghua University. About (NASDAQ: YXT) is a technology company focusing on enterprise productivity solutions. With a mission to "Empower people and organization development through technology," The Company strives to become the supreme provider in building and boosting enterprise productivity by combining over a decade of experience in tech-enabled talent learning and development and with AI-augmented task copilots and unleashing the power of knowledge and synergy. Since its inception, has supported and received recognition from numerous Global and China Fortune 500 companies. operates its business in China through "Jiangsu Radnova Intelligence Technology Co., Ltd.," formerly known as "Jiangsu Yunxuetang Network Technology Co., Ltd.". has established an entity in Singapore to serve as a headquarter for its overseas business to be conducted in the future, with the "Radnova" trademark to serve international markets. Safe Harbor StatementThis press release contains forward-looking statements. These statements are made under the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as 'may,' 'will,' 'expect,' 'anticipate,' 'target,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to', or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law. ContactRobin YangICR, (646) 405-4883
Forbes
26 minutes ago
- Forbes
From Expense To Asset: How Today's AI Investments Can Save You Money
Michael Ringman is CIO at TELUS Digital (formerly TELUS International), providing digital-first, AI-fueled customer experiences. Whatever sector you're in, you've no doubt been thinking about the mounting pressures facing your business. Now more than ever, it's critical to strategically prioritize any and all investments. If you're looking for a sign to invest in generative AI (GenAI) solutions, here it is: According to a 2024 IDC–Microsoft survey of 4,000 business leaders tasked with bringing AI into their operations, for every dollar invested, you can expect to get about 3.7 times back. And that ROI is projected to climb as both GenAI and its adoption continue to grow. However, realizing this ROI takes time. According to KPMG, as reported in The CFO, "nearly 70% of leaders plan to spend between $50 million and $250 million on related [GenAI] Yet as we look to the future of GenAI, it's clear that the efficiency gains, cost savings and competitive advantages are too significant to ignore. With more successful use cases emerging and GenAI tools maturing rapidly, the question is no longer if businesses should invest in this technology, but how to do it right. Spending Money To Save Money It may feel counterintuitive to invest in new technologies when markets are facing uncertainty, but GenAI is already making tangible differences. Microsoft recently published a list of 261 success stories about how its GenAI solutions were used to save money, amplify efficiencies, drive productivity and extend the capabilities of organizations globally. Regardless of economic conditions, customers' expectations of digital experiences will never decline. If anything, those expectations will continuously rise as competitors and new market entrants set higher bars for service. Those bars are greatly influenced by companies' embrace of new and emerging technologies. Nvidia's "State of AI in Financial Services" survey notes that one of the top GenAI ROI use cases is customer experience (CX) and engagement. Notably, the report states that the use of GenAI for CX "has more than doubled, rising from 25% to 60%. This surge is driven by the increasing availability, cost efficiency and scalability of generative AI technologies for powering more sophisticated and accurate digital assistants that can enhance customer interactions." The report also says roughly two-thirds of respondents saw AI drive a 5% increase in revenue and a 5% reduction in annual costs. It also tracked an uptick in the number of companies using GenAI, and in the variety of ways the technology is used. GenAI can be deployed both as agent-facing tools to empower employees and as customer-facing solutions, including autonomous AI agents, to handle interactions independently. But these applications aren't the only ways AI drives value. Meaningfully supporting your company's ability to serve and engage customers takes a more profound and big-picture implementation across the employee experience, business operations, hiring processes and supply chain management. Only when your company is working in harmony across all departments can you fully realize the ROI potential of your AI investments. Bringing GenAI Assistants Into The Fold GenAI has changed the way companies handle communications, information, performance data and innovation. Employees are increasingly turning to GenAI tools to enhance their productivity, streamline workflows and tackle complex problems more efficiently. This is happening whether or not your company has adopted and implemented GenAI. Recently, my firm, TELUS Digital, revealed that a majority of employees depend on GenAI assistants in their day-to-day work and will use publicly available large language models (LLMs) like ChatGPT if none are available internally. What's more, 57% of respondents admitted to entering sensitive information, including customer names and contact details, into publicly available GenAI assistants, making the need for a secure, enterprise-safe GenAI platform even more evident. Unsurprisingly, employees reported that GenAI assistants helped them work faster, improved their performance and reduced strain caused by repetitive tasks, but the availability of GenAI assistants also has impacts on talent acquisition and recruitment. In fact, our survey found that 44% of employees would be more likely to quit if their company didn't allow AI assistants, and 59% said they'd prioritize applying for jobs at companies that allow AI assistant usage. GenAI is becoming an increasingly crucial part of employees' day-to-day lives, and businesses can no longer simply ban the use of AI at work. Given the workforce demand for GenAI assistants, it's incumbent upon companies to embrace GenAI and work to fill skill gaps now. The Cost Of Inaction Regardless of data to the contrary, many business leaders believe GenAI may still be too risky to invest in. Choosing to delay adoption is not the safe bet some may think it is. Late adopters may experience escalating implementation costs, widening skill gaps and dissatisfaction among customers who are benefiting from AI-enabled services elsewhere. The reality is, the capabilities of safe and responsible GenAI are expanding by leaps and bounds every day. McKinsey recently noted that transparency and explainability of some of the leading LLMs doubled or tripled between 2023 and 2024, based on Stanford University's Transparency Index. GenAI is continually becoming better at accuracy, reasoning and even independent decision-making. For those considering GenAI investments, best practices dictate a few clear steppingstones: • Conduct an AI readiness assessment. • Start small with pilot projects with a fast time to value. • Develop a phased implementation strategy. • Establish clear benchmarks and KPIs for tracking ROI and other metrics. • Develop comprehensive training programs and risk and governance frameworks that include human oversight. • Work with an experienced partner to benefit from their expertise, technology and economies of scale. Taking The Leap To drive efficiencies and reduce costs on a sustainable basis means investing strategically in AI today. As our executive vice chair of the board, Jeff Puritt, previously shared, "Whether your organization is poised to thrive, highly constrained, or in a fight to survive, investments in your people, technology, and communities are measurably beneficial to the bottom line. ... Doing the right thing is the right way to inoculate your business against exogenous events, while positioning your brand for sustainable growth in even the most trying of times." Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
WIRED
29 minutes ago
- WIRED
Microsoft Says Its New AI System Diagnosed Patients 4 Times More Accurately Than Human Doctors
Jun 30, 2025 9:00 AM The tech giant poached several top Google researchers to help build a powerful AI tool that can diagnose patients and potentially cut health care costs. Microsoft built an AI system called the MAI Diagnostic Orchestrator that the company says can diagnose ailments. Photograph:Microsoft has taken 'a genuine step towards medical superintelligence,' says Mustafa Suleyman, CEO of the company's artificial intelligence arm. The tech giant says its powerful new AI tool can diagnose disease four times more accurately and at significantly less cost than a panel of human physicians. The experiment tested whether the tool could correctly diagnose a patient with an ailment, mimicking work typically done by a human doctor. The Microsoft team used 304 case studies sourced from the New England Journal of Medicine to devise a test called the Sequential Diagnosis Benchmark (SDBench). A language model broke down each case into a step-by-step process that a doctor would perform in order to reach a diagnosis. Microsoft's researchers then built a system called the MAI Diagnostic Orchestrator (MAI-DxO) that queries several leading AI models—including OpenAI's GPT, Google's Gemini, Anthropic's Claude, Meta's Llama, and xAI's Grok—in a way that loosely mimics several human experts working together. In their experiment, MAI-DxO outperformed human doctors, achieving an accuracy of 80 percent compared to the doctors' 20 percent. It also reduced costs by 20 percent by selecting less expensive tests and procedures. "This orchestration mechanism—multiple agents that work together in this chain-of-debate style—that's what's going to drive us closer to medical superintelligence,' Suleyman says. The company poached several Google AI researchers to help with the effort—yet another sign of an intensifying war for top AI expertise in the tech industry. Suleyman was previously an executive at Google working on AI. AI is already widely used in some parts of the US health care industry, including helping radiologists interpret scans. The latest multimodal AI models have the potential to act as more general diagnostic tools, though the use of AI in health care raises its own issues, particularly related to bias from training data that's skewed toward particular demographics. Microsoft has not yet decided if it will try to commercialize the technology, but the same executive, who spoke on the condition of anonymity, said the company could integrate it into Bing to help users diagnose ailments. The company could also develop tools to help medical experts improve or even automate patient care. 'What you'll see over the next couple of years is us doing more and more work proving these systems out in the real world,' Suleyman says. The project is the latest in a growing body of research showing how AI models can diagnose disease. In the last few years, both Microsoft and Google have published papers showing that large language models can accurately diagnose an ailment when given access to medical records. The new Microsoft research differs from previous work in that it more accurately replicates the way human physicians diagnose disease—by analyzing symptoms, ordering tests, and performing further analysis until a diagnosis is reached. Microsoft describes the way that it combined several frontier AI models as 'a path to medical superintelligence,' in a blog post about the project today. The project also suggests that AI could help lower health care costs, a critical issue, particularly in the US. "Our model performs incredibly well, both getting to the diagnosis and getting to that diagnosis very cost effectively," says Dominic King, a vice president at Microsoft who is involved with the project. 'It is quite exciting,' says David Sontag, a scientist at MIT and cofounder of Layer Health, a startup that builds medical AI tools. Sontag says the work is important not only because it more closely mirrors the way physicians operate but also because it is rigorous about addressing potential issues with the underlying methodology. 'That's what makes this paper strong,' he says. But Sontag says that Microsoft's findings should be treated with some caution because doctors in the study were asked not to use any additional tools to help with their diagnosis, which may not be a reflection of how they operate in real life. He adds that it remains to be seen whether the AI system would significantly reduce costs in practice. The doctors involved in the study may have taken into account factors that the AI could not, such as a patient's tolerance for a procedure or the availability of a particular medical instrument. 'This is an impressive report because it tackles highly complex cases for diagnosis,' says Eric Topol, a scientist at the Scripps Research Institute. Showing that AI could, in theory, reduce the cost of medical care is novel, he adds. Both Topol and Sontag of MIT say that the next step in validating the potential of Microsoft's system ahead of general deployment would be demonstrating the tool's effectiveness in a clinical trial comparing its results with those of real doctors treating real patients. 'Then you can get a very rigorous evaluation of cost,' Sontag says.
